Test Price
2,800 AED✅ Home Collection Available
OTOF Gene Deafness (Autosomal Recessive Type 9) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing
- Premium Logistics: Hospital-Grade Home Collection via Temperature-Controlled Cold-Chain
- VIP Mobile Phlebotomy: 8 AM – 11 PM, 7 days a week
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
- Price: 2,800 AED (all-inclusive)
- Turnaround Time: 3–4 Weeks
Test Overview & Methodology
The OTOF Gene NGS Test identifies pathogenic variants in the OTOF gene linked to autosomal recessive nonsyndromic hearing loss (DFNB9) with 99.9% diagnostic accuracy. This comprehensive genetic test uses Next Generation Sequencing to analyze the entire OTOF gene, enabling precise diagnosis and personalized management, including cochlear implantation evaluation.
| Feature | Our OTOF NGS Test | Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) | Sanger Sequencing |
| Detection Rate | >99.9% for point mutations, indels, CNVs | ~95% for known variants only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sample Options | Blood, Extracted DNA, FTA Card | Blood or DNA only |
| Genetic Counseling | Included (Pre & Post-Test) | Often Limited |
| DHA Facility License | Yes (License No. 1143) | Variable |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I consider the OTOF NGS test a cornerstone for early diagnosis of DFNB9, especially when cochlear implantation is being evaluated. Please remember that this genetic result must be correlated with comprehensive audiological assessment and family history. Never make treatment decisions without consulting your supervising clinician.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Note
Medication Warning:
Do not discontinue any prescribed medication or alter therapy without explicit guidance from your physician. Genetic results do not replace clinical management.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Severe coagulopathy, active bacteremia, or inability to provide informed written consent (including minors without guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Red Flags After Blood Draw: Seek emergency care if you experience excessive bleeding, hypotension, syncope, or signs of infection (redness, swelling, pus) at the puncture site.
- Minors: Genetic testing for individuals under 18 requires parental/legal guardian consent and genetic counseling in accordance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the OTOF gene test and why is it needed?
Snippet killer: It detects mutations in the OTOF gene causing autosomal recessive nonsyndromic hearing loss DFNB9 to guide cochlear implant candidacy.
This test is essential for newborns and children with unexplained bilateral sensorineural hearing loss, as OTOF mutations account for a significant proportion of genetic deafness. Identifying a biallelic mutation confirms the diagnosis and helps predict excellent outcomes with cochlear implantation, avoiding unnecessary diagnostic odysseys.
2. How accurate is this NGS test and what do the results mean?
Snippet killer: The test offers 99.9% analytical sensitivity for detecting all pathogenic variants in the OTOF gene through NGS.
Results are classified as positive (two pathogenic mutations found, confirming DFNB9), negative, or variant of uncertain significance (VUS). Our genetic counselor will explain implications for hearing rehabilitation, including cochlear implant timing, and offer family risk assessment for future pregnancies.
3. How is the sample collected? Is home collection available?
Snippet killer: A simple blood draw or FTA card finger stick can be collected at home by a DHA-licensed phlebotomist.
We provide VIP home collection service from 8 AM to 11 PM daily. The sample is transported in cold-chain packaging to our ISO 9001:2015 certified laboratory. You can also submit extracted DNA if previously stored. The whole process is painless and toddler-friendly, with results ready in 3–4 weeks.
UAE Regulatory & Data Privacy Adherence
All genetic and personal data handled as per Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Data is stored within UAE servers and not shared without explicit consent. Testing protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability for safety and patient consent.
Clinical & Logistical Metadata
| Test Name | OTOF Gene Deafness (Autosomal Recessive Type 9) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | H90.5, H90.3 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians